DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Nauck MA, Del Prato S, Meier JJ et al.
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin A randomized, 52-week, double-blind, active-controlled noninferiority trial.
Diabetes Care 2011;
34: 2015-2022
We do not assume any responsibility for the contents of the web pages of other providers.